BODI Q2 FY2026 Sankey: $50M revenue, -22.4% YoY
BODICIK 1826889SEC EDGAR
Quarter Comparison
Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
ComparingFY2026 (Q2) vs FY2025 (Q2)
Compare:
The breakdowns we can show depend on the figures we hold for each company. A greyed option is one we cannot show for this company; “No breakdown” is always available.
Historical trends unavailable The historical series for this company could not be loaded, so a node cannot open its trend right now. The figures drawn below are unaffected.
Show Source Data (Audit Panel)
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $49.61M | $63.94M |
| COGS | $13.87M | $17.7M |
| Gross Profit | $35.75M | $46.24M |
| R&D | $0 | — |
| SG&A | $24.19M | $37.1M |
| Selling And Marketing Expense | $15.63M | $25.53M |
| General And Administrative Expense |
QuarterCharts · SEC EDGAR data · BODI · Comparing FY2026 (Q2) vs FY2025 (Q2)